Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026.
- Largest single sale: $1.4M (15,000 shares) of Incyte on May 19, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Incyte (INCY) | Director | Jan 22, 2015 | Oct 2, 2026 |
| Sionna Therapeutics, Inc. (SION) | Director | Feb 6, 2025 | Jun 18, 2026 |
| Biogen (BIIB) | Former Executive VP and CFO | Aug 21, 2007 | Apr 27, 2017 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 30, 2026, Incyte: 203 shares awarded. 1 filing: 1
- Jun 30, 2026, Incyte: 252 shares awarded. 1 filing: 1
- Jun 8, 2026, Incyte: 1,642 shares granted. 1 filing: 1
- May 19, 2026, Incyte: sold 15,000 shares for $1.4M, under a disclosed plan; 15,000 shares acquired by exercising options. 1 filing: 1
- Mar 31, 2026, Incyte: 265 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.